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Abstract:  
Objective: Sleep disturbance and excessive daytime sleepiness have been reported in patients 
with hepatic cirrhosis. The objective of this study was to evaluate daytime somnolence and 
sleep complaints in a group of 178 patients with cirrhosis compared to a control group. 
Method: Sleep features and excessive daytime sleepiness were evaluated by the Basic Nordic 
Sleep Questionnaire (BNSQ) and the Epworth Sleepiness Scale (ESS). We collected clinical 
and laboratory data, neurological assessment and EEG recording in cirrhotic patients. 
Results: Patients with cirrhosis complained of more daytime sleepiness (p<0.005), sleeping 
badly at least three times a week (p<0.005), difficulties falling asleep (p<0.01) and frequent 
nocturnal awakening (p<0.005) than controls. We found a poor correlation between sleep 
disorders and clinical or laboratory parameters. Conclusion: Our results confirm previous 
literature reports suggesting a high prevalence of sleep disturbance in patients with cirrhosis. 
Insomnia and daytime sleepiness are the main complaints. Sleep disorders are probably a 
multifactorial phenomenon. 
 
Key words: liver cirrhosis, insomnia, daytime somnolence. 
 
 
 
 
 
 
 
 
  
3 
 
Introduction 
Sleep disturbance and excessive daytime somnolence are common in patients with cirrhosis 
[1, 2, 3, 4]. In addition, a disturbance of sleep is recognized as one of the early signs of 
hepatic encephalopathy [5, 6, 7]. Reversal of sleep rhythm, drowsiness and lethargy are 
classic signs of this disease, and their presence and entity are used to define the clinical stages 
of hepatic encephalopathy [8, 9, 10, 11].  
The most common feature of the sleep pattern in patients with cirrhosis is fragmented 
nocturnal sleep caused by frequent nocturnal awakenings, and a daytime functioning affected 
by frequent episodes of undesired sleepiness and more prolonged napping time [1, 2]. The 
sleep-wake cycle was also shifted with activity toward the later hours of the day. This was 
ascribed to the displacement toward later hours in the 24-hour profile of plasma melatonin, 
common in cirrhosis [12]. However, the existence of a phase delay in cirrhotic patients and its 
relation with the melatonin rhythm remains controversial [13]. In addition, few data showed a 
correlation between sleep impairment and the clinical parameters of liver disease. There are 
limited data on the true prevalence of sleep disturbance in cirrhotic patients compared with a 
control group. 
For these reasons, we conducted a case control study to assess the prevalence and 
characteristics of sleep disturbance and excessive daytime sleepiness in patients with cirrhosis 
compared with a sex and age matched non-cirrhotic population, and to determine their 
correlation with clinical parameters. 
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Materials and methods 
Participants 
Patients with cirrhosis. We studied a consecutive series of 178 patients with hepatic cirrhosis. 
All patients with a diagnosis of liver cirrhosis not alcohol related seen at our Neurology Unit 
were invited to participate in this study. Patients were referred to our Unit either for 
neurological screening for orthotopic liver transplantation (112 patients) or for any 
neurological complaint (including hepatic encephalopathy). Patients with post-alcoholic 
cirrhosis were excluded due to the possible independent influence of ethanol on the central 
nervous system and quality of sleep. 
One hundred and fifteen males and sixty-three females, whose mean age was 52.12 years                 
(ranging from 17 to 71 years) were enrolled. 
The diagnosis of cirrhosis was based on a compatible clinical history, radiological studies, 
and liver biopsy when available. 
At the time of evaluation, 23.5% were Child-Pugh class A patients, 48.2% class B and 28.3% 
class C. The aetiology of cirrhosis was viral hepatitis in 78.6% (HBV 18.5%; HCV 53.4%; 
HBV+HCV 6.7%), autoimmune disease in 9% and diverse causes in 11.4%. 24.2% of patients 
referred past episodes of hepatic encephalopathy, 6.2% had current minimal hepatic 
encephalopathy and 68% had never had episodes of encephalopathy. 136 patients were on the 
list for orthotopic liver transplantation. 
Healthy controls. A control group was selected from healthy subjects, mostly blood donors at 
our hospital and employees from our institution. The group included 178 individuals sex and 
age matched with the cirrhotic patients (+/- 1 year). Mean age of normal controls was 52.06 
years (ranging from 17 to 72 years). 
The study was conducted according to the principles established in Helsinki and approved by 
the local ethical committee. 
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Procedures 
Neurological assessment. A complete neurological assessment was performed in all patients 
with cirrhosis. One-hundred-thirteen patients underwent EEG recording. 
Sleep Evaluation. All patients with cirrhosis were assessed by a sleep specialist with a semi-
structured 20 minute interview on their sleep habits and complaints. All subjects were 
administered two standardised questionnaires: the Basic Nordic Sleep Questionnaire (BNSQ) 
and the Epworth Sleepiness Scale (ESS).  
The BNSQ comprises 22 questions investigating sleep habits and complaints of insomnia, 
difficulty falling asleep, night awakenings, early morning awakening, use of hypnotic drugs, 
napping habits, daytime sleepiness, snoring and sleep apnoea [14]. 
We added two questions to better define the severity of daytime sleepiness and the 
circumstance in which sleepiness occurred. The questions added were: “Do you feel 
excessively sleepy during the daytime?” 1-never 2-sometimes after lunch 3-often or always 
after lunch 4-even at other times of the day 5-throughout the day; and “Sleepiness is” 1-absent 
2-slight 3-moderate 4-severe 5-very severe. Most of the questions ask for the frequency of the 
symptom (never or less than once per month, less than once per week, on 1-2 days per week, 
on 3-5 days per week, daily or almost daily), other than the severity of the symptom. 
The ESS is a standardised scale scoring the level of daytime sleepiness by rating the chance 
the subject would doze off in eight different real-life situations [15]. The questionnaires were 
administered by a physician. 
All subjects were classified on the basis of their answers to the BNSQ questions as Sleepy (S) 
if they complained of excessive daytime sleepiness, at least moderate and not only in the 
postprandial hours at least three times a week, Postprandial Sleepy (PS) if they complained of 
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excessive daytime sleepiness at least moderate only after lunch at least three times a week, or 
Not Sleepy (NS) if they did not fit these conditions. Subjects were classified as Insomniacs if 
they reported sleeping badly or rather badly at least three times a week. 
Clinical and laboratory data. We included in the database information on education, 
employment, routine biochemistry, including albumin and serum bilirubin, prothrombin 
activity, cholesterol, alkaline phosphatase, blood ammonia, transaminase, γ-glutamyl 
transpeptidase, γ-globulins, serum triglyceride level, α-fetoprotein, blood nitrogen and current 
therapy. We also investigated the presence and severity of ascites, episodes of 
encephalopathy, gastrointestinal bleeding and jaundice. 
 
Statistical Analysis 
We used t test, variance analysis (ANOVA), Wilcoxon and Mann-Whitney test. Data were 
analysed by the McNemar test. We related all questionnaire answers to blood ammonia value 
with Pearson’s correlation. 
 
Results 
Patients with cirrhosis showed a significantly higher prevalence of sleep disturbance than the 
healthy control group. 
Twenty-six per cent of patients complained of sleeping badly or almost badly at least three 
times a week (“insomniacs”), whereas this complaint was infrequent in the healthy subjects 
(7.9%) (p<0.005).  
Patients with cirrhosis complaining of “insomnia” reported more often both difficulty 
initiating and maintaining sleep but they also differed from “non–insomniac” patients with 
cirrhosis for a higher prevalence of daytime sleepiness (p<0.001) and more frequent naps 
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(p<0.01). No difference was observed between groups regarding early morning awakening 
and snoring.  
Patients with cirrhosis showed a significantly higher prevalence of daytime sleepiness 
(p<0.005): 18.5% were classified as Sleepy (vs. 3.9% of controls), 30.9% referred 
Postprandial Sleepiness (vs. 18.5% of controls) and 50.6% were classified as Not Sleepy 
(vs.77.5% of controls).  
Among patients with cirrhosis 55% referred habitual naps vs. 23% of healthy controls; the 
patients with cirrhosis reported more prolonged napping tim. (table 1). Among cirrhotic 
patients, the Sleepy group showed worsening parameters of nocturnal sleep quality, like 
nocturnal awakening (p<0.05), difficulties falling asleep (p<0.05), complaint of sleeping 
badly or almost badly at least three times a week (p<0.005) and referred sleep apnea (p<0.05).  
Patients with cirrhosis had a mean ESS score of 6.66 (vs. 6.17 in healthy controls), and 15.7% 
of them had a score higher than 10 (vs. 12.9% in healthy controls), but the difference was not 
statistically significant. The patients  with the highest scores, although not pathological, were 
patients complaining of “insomnia”. Among patients with cirrhosis those with current 
minimal hepatic encephalopathy  were more frequently “sleepy”  (p<0.005) and  “insomniac” 
(p<0.05) . 
 
 
Table 1 Characteristics of sleep among groups 
 
 
No significantly difference was observed between Sleepy and Postprandial or Not Sleepy 
cirrhotic patients with regard to Child-Pugh score, development of ascites, aetiology of 
cirrhosis, previous encephalopathy and routine biochemistry. The mean value of blood 
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ammonia was 61.79 mcg/dl in Postprandial and Not Sleepy, and 76.88 in Sleepy patients, but 
the difference was not significant (ANOVA). We tried to divide patients into two groups, 
according to pathological or normal blood ammonia value (≤ or > 80 mcg/dl), and the two 
groups were compared according to parameters of sleep habits: they did not show significant 
differences. Moreover, blood ammonia value did not show any significant correlation with 
parameters of sleep quality. 
Bedtime and wake-up time of patients with cirrhosis and healthy controls were similar (mean 
value of bedtime in cirrhotics: 23.16 vs. controls: 23.53; mean value of wake-up time in 
cirrhotics: 7.46 vs. controls: 7.36). Even comparing cirrhotic patients with sleep disturbance 
and those without, these parameters did not differ between groups (mean value of bedtime 
and wake-up time in insomniac cirrhotic group: 23.07 and 7.18; in non-insomniac cirrhotic 
group: 23.19 and 7.15).  
 
Discussion 
Our study confirms that patients with cirrhosis frequently have sleep disorders. We found a 
significantly higher prevalence of parameters of poor sleep quality, like difficulties falling 
asleep, nocturnal awakenings and complaints of sleeping badly in patients with cirrhosis than 
in healthy controls. In addition, daytime functioning of these patients was affected by 
excessive sleepiness and more prolonged napping time. A higher prevalence of daytime 
sleepiness  disclosed by the BNSQ questionnaire was not accompanied by a significant 
different in the Epworth Sleepiness Scale (ESS). This may be because the ESS, validated in 
narcoleptics and OSAS patients, is not sufficiently accurate in estimating sleepiness in an 
inactive population like patients with cirrhosis [16]. As reported in previous studies, we found 
a poor correlation between clinical and laboratory parameters and sleep disturbance or 
daytime somnolence [17, 18]. We did not find a phase delay in the sleep patterns of patients 
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with cirrhosis, although the sleep questionnaire we used is not an accurate tool to identify 
circadian abnormalities.  
Another limitation of our study is the difficulty defining and estimating sleepiness on the 
basis of subjective patient evaluation. The first problem is to distinguish sleepiness from 
common symptoms in cirrhosis, like fatigue, tiredness and lack of energy. 
Sleepiness could also be linked to the limitations of a chronic disease forcing subjects to lead 
very sedentary lives, thereby increasing the risk of episodes of undesired sleepiness. In 
addition, the frequent nocturnal awakenings could be related to more episodes of nicturia 
because of diuretic treatment. In this regard, another limitation in our study is the lack of a 
control group with another chronic disease (e.g. chronic renal failure). Sleep difficulty  in 
patients with cirrhosis could be related to a specific dysregulation of the histamine 
neurotrasmitter system ( 19,20), and a comparison with other chronic diseases could yield 
information useful to estimate the real impact of hepatic failure on the sleep pattern and its 
pathogenesis. 
Snoring and reported apnoeas did not significantly differ from healthy controls. However, the 
finding that snoring was more common in “sleepy” than in “post-prandial sleepy” and “not 
sleepy” patients with cirrhosis in our cohort could strengthen the hypothesis that somnolence 
in cirrhotic patients is favoured at least in part by an obstructive apnoea syndrome during 
sleep ( 21,22,23) .   
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Table 1 Characteristics of sleep among groups 
 
 Cirrhotic Patients Healthy Controls P 
Sleepy  (%) 
Post-prandial Sleepy (%) 
Not Sleepy (%) 
18.5 
30.9 
50.6 
3.9 
18.5 
77.5 
0.005 
“Insomnias “(%) 26 7.9 0.005 
Difficulty falling asleep 
(%) 
21 8.5 0.01 
Night Awakening (%) 71 43 0.005 
Early awakening (%) 15 12 n.s. 
Hypnotics (%) 4.5 2.3 n.s. 
Morning sleepiness (%) 19 12 n.s. 
Sleep attacks (%) 6.8 3.4 n.s. 
Total sleep time (min) 450 442 n.s. 
Snoring (%) 26 35 n.s. 
Referred sleep apnea (%) 4.1 5.4 n.s. 
NAP (%) 
Duration ( min)  
55 
38.8 
23 
26.9 
0.005 
0.05 
 
 
